Physician profile
Anmar Razak
NPI 1154545853
$85,927.58
in general payments reported to CMS, 2019-2025
31 companies · $7,778 in 2025
The $7,778 reported for 2025 was more than what 90% of Vascular Neurology providers received nationally (typical 2025 total: $360).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $22K · 2020: $7,784 · 2021: $26K · 2022: $15K · 2023: $5,354 · 2024: $1,539 · 2025: $7,778.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $10K · Food and Beverage: $4,356 · Travel and Lodging: $150.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $10,165.00 |
| Food and Beverage | $4,355.89 |
| Travel and Lodging | $149.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $66,834.54 | 2019-2024 | Xarelto |
| Portola Pharmaceuticals, LLC | $6,513.16 | 2019 | |
| Medtronic, INC. | $6,249.39 | 2022-2025 | Linq II, Solitaire X, Pipeline |
| Penumbra, INC. | $2,284.87 | 2019-2025 | Penumbra System, Benchmark, Red 72 |
| Stryker Corporation | $1,187.01 | 2019-2025 | Trevo, Target, Evolve Proline |
| Microvention, INC. | $651.58 | 2019-2024 | Stent, Web Aneurysm Embolization System, Hydrosoft Advanced |
| Imperative Care, INC | $483.46 | 2023-2025 | Zoom 88-T Large Distal Platform |
| Depuy Synthes Sales INC. | $273.59 | 2023-2024 | Trufill, Cerebase, Embotrap |
| Shockwave Medical, INC | $271.44 | 2022-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Medtronic USA, INC. | $234.29 | 2019-2020 | |
| Astrazeneca Pharmaceuticals Lp | $120.50 | 2024 | Andexxa |
| Novo Nordisk INC | $118.31 | 2023 | |
| Route 92 Medical, INC. | $93.48 | 2025 | |
| Genentech USA, INC. | $78.38 | 2019-2025 | Evrysdi, Ocrevus Zunovo |
| Ucb, INC. | $60.45 | 2024-2025 | Fintepla, Nayzilam, Briviact |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alnylam Pharmaceuticals INC. | $55.45 | 2025 | Onpattro |
| Jazz Pharmaceuticals INC. | $53.26 | 2022-2024 | |
| Biogen, INC. | $44.38 | 2025 | Tysabri |
| Lilly USA, LLC | $42.76 | 2025 | Kisunla, Amyvid |
| Impulse Dynamics (USA) INC. | $38.79 | 2023 | Optimizer |
| Takeda Pharmaceuticals U.S.A., INC. | $28.63 | 2025 | Hyqvia |
| Neurelis, INC. | $28.34 | 2023-2025 | Valtoco |
| Kaneka Medical America LLC | $28.29 | 2024 | |
| Eisai INC. | $26.57 | 2025 | |
| Tg Therapeutics, INC. | $24.10 | 2025 | |
| Abbott Laboratories | $20.78 | 2019 | |
| Aucta Pharmaceuticals, INC. | $19.34 | 2025 | Motpoly Xr |
| Argenx US, INC. | $18.90 | 2023 | Vyvgart Hytrulo |
| Boston Scientific Corporation | $17.22 | 2024 | Watchman Flx |
| Abbvie INC. | $14.52 | 2023 | |
| Chiesi USA, INC. | $11.80 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anmar Razak listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.